COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.

COVID-19 关闭:医疗保健中断对纽约市多种慢性病患者心血管健康差异的影响。

基本信息

  • 批准号:
    10436056
  • 负责人:
  • 金额:
    $ 71.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY In the first half of 2020, the SARS-CoV-2 (COVID-19) pandemic infected nearly 4 million persons in the U.S. and caused over 150,000 deaths. In the midst of the early phase of this pandemic, people with multiple chronic conditions (MCC) including diabetes, hypertension, obesity, and dyslipidemia, which are increasingly common with age, were left extremely vulnerable to disruptions in healthcare delivery; in New York City (NYC), the first U.S. epicenter of the COVID-19 outbreak, traditional ambulatory care ceased entirely for several months and then reopened at only limited capacity. Implementation of telemedicine and modified in-person visits to bridge this gap was attempted but adopted unevenly, and differential uptake may have worsened existing health disparities. In this context, the unprecedented pandemic-disruption in ambulatory care in NYC provides a singular opportunity to study the long-term effects of disasters on health care systems serving health disparity populations. Our institution, NYU Grossman School of Medicine (NYUGSOM), is uniquely positioned to answer these questions, having been at the center of the COVID-19 pandemic in NYC. We have robust existing data partnerships with the INSIGHT Clinical Research Network, which includes a standardized electronic health record (EHR) network of 5 NYC academic medical centers, and with the NYC Health and Hospitals Corporation (NYC-H+H), the largest public hospital system in the U.S. We will leverage these 2 sources to determine, among people age ≥50 with MCCs (≥2 chronic medical conditions), whether patterns of health system engagement during the acute pandemic disruption phase (3/7/20-7/9/2020) influenced trajectories of 2 chronic diseases (hypertension and diabetes) at 2 years, risk of cardiovascular events at 4 years, and whether disparities in engagement exacerbated health inequities. In Aim 1 we will characterize ambulatory healthcare utilization and quantify disruptions in healthcare services (total disruption vs. delayed care vs. sufficient care) during the acute pandemic phase, overall and by subgroup (e.g. racial/ethnic minority, economically disadvantaged). In Aim 2 we will then assess the impact of total disruption and delayed care in healthcare on 2-year trajectories of chronic disease measures (mean systolic blood pressure, hemoglobin A1c), and in Aim 3 we will measure the impact of healthcare disruptions on major adverse cardiovascular outcomes in the 4 years after the acute pandemic period, and identify their impacts on disparities in CVD outcomes using causal mediation analysis methods. Our findings will guide future disaster preparedness planning and allow health care systems to develop optimal care models to mitigate CVD risk and avoid worsening disparities among socioeconomically disadvantaged and/or minority populations. The MPIs for this project (Dr. Dodson and Dr. Thorpe) combine research experience in cardiovascular medicine, gerontology, epidemiology, and data science, and are joined by Co-I’s (Dr. Divers, Dr. Adhikari, Dr. Vedanthan, Dr. Blecker, Dr. Weiner) who bring expertise in health disparities research, implementation science, biostatistics, and use of EHRs.
项目概要 2020 年上半年,SARS-CoV-2 (COVID-19) 大流行在美国感染了近 400 万人, 在这场大流行的早期阶段,患有多种慢性病的人已造成超过 15 万人死亡。 疾病 (MCC) 包括糖尿病、高血压、肥胖和血脂异常,这些疾病越来越常见 随着年龄的增长,纽约市 (NYC) 极易受到医疗服务中断的影响; 美国是 COVID-19 爆发的中心,传统的门诊护理完全停止了几个月, 然后以有限的能力重新开放,实施远程医疗并修改亲自访问桥梁。 尝试过这种差距,但采用不均匀,不同的吸收可能会恶化现有的健康状况 在这种情况下,纽约市门诊护理中前所未有的大流行中断提供了一个独特的机会。 有机会研究灾害对服务于健康差距的医疗保健系统的长期影响 我们的机构纽约大学格罗斯曼医学院 (NYUGSOM) 具有独特的优势来回答这一问题。 这些问题一直是纽约市 COVID-19 大流行的核心问题,我们拥有可靠的现有数据。 与 INSIGHT 临床研究网络建立合作伙伴关系,其中包括标准化电子健康 纽约市 5 个学术医疗中心以及纽约市健康与医院公司的记录 (EHR) 网络 (NYC-H+H),美国最大的公立医院系统。我们将利用这两个来源来确定: 年龄 ≥ 50 岁患有 MCC 的人(≥ 2 种慢性疾病),无论卫生系统的参与模式 在急性大流行破坏阶段(2020年7月3日至9月7日)影响了2种慢性疾病的发展轨迹 2 年时(高血压和糖尿病)、4 年时心血管事件的风险,以及是否存在差异 在目标 1 中,我们将描述门诊医疗保健的利用和参与加剧了健康不平等。 量化急性发作期间医疗保健服务的中断(完全中断与延迟护理与充分护理) 总体和按亚组(例如种族/族裔、经济弱势群体)的大流行阶段。 然后将评估医疗保健领域的全面中断和延迟护理对慢性病 2 年轨迹的影响 疾病测量(平均收缩压、A1c 血红蛋白),在目标 3 中,我们将测量以下因素的影响 急性大流行期后 4 年内医疗保健中断对主要不良心血管结局的影响, 并使用我们的研究结果确定它们对 CVD 结果差异的影响。 将指导未来的备灾规划,并允许医疗保健系统开发最佳的护理模式 降低心血管疾病风险并避免社会经济弱势群体和/或少数群体之间的差距恶化 该项目的 MPI(Dodson 博士和 Thorpe 博士)结合了以下领域的研究经验: 心血管医学、老年学、流行病学和数据科学,并由 Co-I 加入(Dr. Divers、Dr. Adhikari、Vedanthan 博士、Blecker 博士、Weiner 博士)带来了健康差异研究方面的专业知识, 实施科学、生物统计学和电子病历的使用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John A Dodson其他文献

Telehealth and Health Equity in Older Adults With Heart Failure: A Scientific Statement From the American Heart Association
患有心力衰竭的老年人的远程医疗和健康公平:美国心脏协会的科学声明
  • DOI:
    10.1161/hcq.0000000000000123
  • 发表时间:
    2023-11-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ruth Masterson Creber;John A Dodson;Julie Bidwell;Khadijah K. Breathett;Courtney Lyles;Carolyn Harmon Still;S. Ooi;C. Yancy;S. Kitsiou
  • 通讯作者:
    S. Kitsiou
Predicting Risk of Alzheimer’s Diseases and Related Dementias with AI Foundation Model on Electronic Health Records
利用电子健康记录上的 AI 基础模型预测阿尔茨海默病和相关痴呆症的风险
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Weicheng Zhu;Huanze Tang;Hao Zhang;H. Rajamohan;Shih;Xinyue Ma;Ankush Chaudhari;Divyam Madaan;Elaf Almahmoud;S. Chopra;John A Dodson;Abraham A Brody;Arjun V. Masurkar;N. Razavian
  • 通讯作者:
    N. Razavian
Evaluating Large Language Models in Extracting Cognitive Exam Dates and Scores
评估大型语言模型提取认知考试日期和分数
  • DOI:
    10.1101/2023.07.10.23292373
  • 发表时间:
    2023-07-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hao Zhang;N. Jethani;Simon Jones;Nicholas Genes;Vincent J. Major;Ian S Jaffe;Anthony B Cardillo;Noah Heilenbach;Nadia Fazal Ali;Luke J Bonanni;A. Clayburn;Zain Khera;Erica C Sadler;Jaideep Prasad;Jamie Schlacter;Kevin Liu;Benjamin Silva;Sophie Montgomery;Eric J Kim;Jacob Lester;Theodore M Hill;Alba Avoricani;Ethan Chervonski;James Davydov;William Small;Eesha Chakravartty;Himanshu Grover;John A Dodson;Abraham A Brody;Y. Aphinyanaphongs;Arjun Masurkar;N. Razavian
  • 通讯作者:
    N. Razavian

John A Dodson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John A Dodson', 18)}}的其他基金

Midcareer award in aging-related subspecialty research
与衰老相关的专业研究中的职业生涯中期奖
  • 批准号:
    10570687
  • 财政年份:
    2023
  • 资助金额:
    $ 71.66万
  • 项目类别:
COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.
COVID-19 关闭:医疗保健中断对纽约市多种慢性病患者心血管健康差异的影响。
  • 批准号:
    10707047
  • 财政年份:
    2022
  • 资助金额:
    $ 71.66万
  • 项目类别:
BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure)
BETTER-BP(加强血压调节的行为经济学试验)
  • 批准号:
    10678781
  • 财政年份:
    2019
  • 资助金额:
    $ 71.66万
  • 项目类别:
Rehabilitation at home using mobile health in older adults after hospitalization for ischemic heart disease (RESILIENT)
使用移动医疗对因缺血性心脏病住院的老年人进行家庭康复(RESILIENT)
  • 批准号:
    10604354
  • 财政年份:
    2019
  • 资助金额:
    $ 71.66万
  • 项目类别:
BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure)
BETTER-BP(加强血压调节的行为经济学试验)
  • 批准号:
    10468046
  • 财政年份:
    2019
  • 资助金额:
    $ 71.66万
  • 项目类别:
BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure)
BETTER-BP(加强血压调节的行为经济学试验)
  • 批准号:
    10227750
  • 财政年份:
    2019
  • 资助金额:
    $ 71.66万
  • 项目类别:
Rehabilitation at home using mobile health in older adults after hospitalization for ischemic heart disease (RESILIENT)
使用移动医疗对因缺血性心脏病住院的老年人进行家庭康复(RESILIENT)
  • 批准号:
    10450751
  • 财政年份:
    2019
  • 资助金额:
    $ 71.66万
  • 项目类别:
Rehabilitation at home using mobile health in older adults after hospitalization for ischemic heart disease (RESILIENT)
使用移动医疗对因缺血性心脏病住院的老年人进行家庭康复(RESILIENT)
  • 批准号:
    10165452
  • 财政年份:
    2019
  • 资助金额:
    $ 71.66万
  • 项目类别:
Rehabilitation at home using mobile health in older adults after hospitalization for ischemic heart disease (RESILIENT)
使用移动医疗对因缺血性心脏病住院的老年人进行家庭康复(RESILIENT)
  • 批准号:
    9973123
  • 财政年份:
    2019
  • 资助金额:
    $ 71.66万
  • 项目类别:
BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure)
BETTER-BP(加强血压调节的行为经济学试验)
  • 批准号:
    10019587
  • 财政年份:
    2019
  • 资助金额:
    $ 71.66万
  • 项目类别:

相似海外基金

Microbiota-Mediated Bidirectional Interactions Between Alcohol Misuse and Post-COVID-19 Syndrome
微生物介导的酒精滥用与 COVID-19 后综合症之间的双向相互作用
  • 批准号:
    10491242
  • 财政年份:
    2021
  • 资助金额:
    $ 71.66万
  • 项目类别:
Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients
评估 SPI-1005 在中度和重度 COVID-19 患者中的安全性和有效性的 2 期、随机、双盲、安慰剂对照、剂量递增研究
  • 批准号:
    10283500
  • 财政年份:
    2021
  • 资助金额:
    $ 71.66万
  • 项目类别:
Microbiota-Mediated Bidirectional Interactions Between Alcohol Misuse and Post-COVID-19 Syndrome
微生物介导的酒精滥用与 COVID-19 后综合症之间的双向相互作用
  • 批准号:
    10392167
  • 财政年份:
    2021
  • 资助金额:
    $ 71.66万
  • 项目类别:
Integrated Metagenomic and Metatranscriptomic Characterization of Inflammatory Chronic Rhinosinusitis Endotypes
炎症性慢性鼻窦炎内型的综合宏基因组学和宏转录组学特征
  • 批准号:
    10186350
  • 财政年份:
    2020
  • 资助金额:
    $ 71.66万
  • 项目类别:
The KIDCOV Study: Assessment of Kidney Injury and Associated Risk Factors for SARS-CoV-2
KIDCOV 研究:评估 SARS-CoV-2 肾损伤及相关风险因素
  • 批准号:
    10216618
  • 财政年份:
    2017
  • 资助金额:
    $ 71.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了